Grifols launches AlphaID cheek swab to screen common genetic risk factor for COPD
Physicians can use the new cheek swab to screen patients with COPD for alpha-1 antitrypsin deficiency (Alpha-1)
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Physicians can use the new cheek swab to screen patients with COPD for alpha-1 antitrypsin deficiency (Alpha-1)
MEDx and Lucence announced a strategic partnership in China to co-develop cancer-care tests
Senza Omnia delivers Nevro's HF10 therapy and all other available SCS frequencies
Hologic’s new SureAccess balloon technology enables physicians to access a variety of uterine cavities effortlessly
In contrast to some active implantable devices, the Axonics r-SNM System can be safely left in place during…
Sahara Lateral is claimed to be first ever 3D-printed lateral expandable fusion device
CCM is an advanced electrical therapy that works by modulating the strength of the heart muscle contraction rather…
The Activa patient programmer provides at-home therapy management for DBS patients
The Sundance SCB will enhance the endovascular revascularisation options for below-the-knee arterial lesions in patients suffering from critical…
NuLids System complements Avenova and leverages salesforce calls on eyecare specialists